Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This study is to assess the pharmacokinetics (PK) of a single dose of pravastatin with and
without concomitant GDC-0810 administration in healthy female subjects of non-childbearing
potential. During Period 1 (Day -1 to Day 4) PK parameters of pravastatin will be determined
in the absence of GDC-0810. During Period 2 (Days 5-28) PK parameters of pravastatin will be
determined in the presence of GDC-0810.